Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Maine Prior Authorization May Be Rechallenged By PhRMA If Harm Is Shown

Executive Summary

Maine's Rx rebate program can be challenged if the prior authorization aspect is harming patients, a federal appeals court said in overturning an injunction against initiation of the discount plan.

You may also be interested in...



PhRMA Takes Michigan Rebate Dispute To Federal Court Ahead Of Payments

The Pharmaceutical Research & Manufacturers of America is moving its challenge against Michigan Medicaid's supplemental rebate program to federal court in advance of the first round of rebate payments

PhRMA Takes Michigan Rebate Dispute To Federal Court Ahead Of Payments

The Pharmaceutical Research & Manufacturers of America is moving its challenge against Michigan Medicaid's supplemental rebate program to federal court in advance of the first round of rebate payments

Tri-State Rx Purchasing Pool Estimates 10% To 15% Savings Over Medicaid

Maine, Vermont and New Hampshire expect to save up to $58 mil. annually on prescription drugs through the Tri-State Prescription Drug Purchasing Pool.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel